ACCP Insider Trading Activity and SEC Form 4 Filings
ACCP insider trading summary
No open-market insider purchases or sales of Access Pharmaceuticals Inc (ACCP) have been reported on SEC Form 4 in the past 12 months.
Latest ACCP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 29, 2012 | Ayer Capital Management, LP | 10% Owner | Sell | $99K (179,157 @ $0.55) |
| Jun 29, 2012 | Jay Venkatesan | 10% Owner | Sell | $99K (179,157 @ $0.55) |
| Jun 29, 2012 | ACM Capital Partners, LLC | 10% Owner | Sell | $99K (179,157 @ $0.55) |
| Jun 29, 2012 | Ayer Capital Partners, LLC | 10% Owner | Sell | $99K (179,157 @ $0.55) |
| Jun 28, 2012 | ACM Capital Partners, LLC | 10% Owner | Sell | $17K (25,000 @ $0.68) |
| Jun 28, 2012 | Ayer Capital Partners, LLC | 10% Owner | Sell | $17K (25,000 @ $0.68) |
| Jun 28, 2012 | Jay Venkatesan | 10% Owner | Sell | $17K (25,000 @ $0.68) |
| Jun 28, 2012 | Ayer Capital Management, LP | 10% Owner | Sell | $17K (25,000 @ $0.68) |
| May 16, 2012 | ACM Capital Partners, LLC | 10% Owner | Sell | $94K (140,300 @ $0.67) |
| May 16, 2012 | Jay Venkatesan | 10% Owner | Sell | $94K (140,300 @ $0.67) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.